Update on the catastrophic antiphospholipid syndrome and the "cAPS registryo"

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 4, 2012, Pages 333-338

  Cervera, Ricard ^a   Espinosa, Gerard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

anticardiolipin antibodies; antiphospholipid antibodies; antiphospholipid syndrome; Asherson syndrome; catastrophic antiphospholipid syndrome; lupus anticoagulant

Indexed keywords

ANCROD; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; DEFIBROTIDE; FRESH FROZEN PLASMA; HEPARIN; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; LOW MOLECULAR WEIGHT HEPARIN; MACROPHAGE MIGRATION INHIBITION FACTOR; METHYLPREDNISOLONE; PROSTACYCLIN; RITUXIMAB; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLEEDING; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG TOLERABILITY; FETUS WASTAGE; HISTOPATHOLOGY; HUMAN; INFECTION PREVENTION; LUNG COMPLICATION; LUNG EDEMA; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG INFILTRATE; MICROTHROMBUS; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE; THROMBOCYTOPENIA; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; CATASTROPHIC ILLNESS; CHILD; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; THROMBOSIS; YOUNG ADULT;

EID: 84861342502     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1304718     Document Type: Article

References (31)

1. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol: 1992; 19 4 508 512
2. Piette JC, Cervera R, Levy RA, Nasonov EL, Triplett DA, Shoenfeld Y. The catastrophic antiphospholipid syndromeAsherson's syndrome. Ann Med Interne (Paris): 2003; 154 4 195 196
3. Asherson RA, Cervera R, Piette JC., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore): 1998; 77 3 195 207 (Pubitemid 28290020)
4. Asherson RA, Cervera R, Piette JC., et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore): 2001; 80 6 355 377 (Pubitemid 33070843)
5. Bucciarelli S, Espinosa G, Cervera R., et al. European Forum on Antiphospholipid Antibodies. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum: 2006; 54 8 2568 2576 (Pubitemid 44205018)
6. Cervera R, Piette JC, Font J., et al. Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum: 2002; 46 4 1019 1027 (Pubitemid 34303815)
7. Asherson RA, Cervera R, de Groot PG., et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus: 2003; 12 7 530 534 (Pubitemid 36890145)
8. Cervera R, Font J, Gmez-Puerta JA., et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis: 2005; 64 8 1205 1209 (Pubitemid 41113358)
9. Cervera R, Bucciarelli S, Plasn MA., et al. Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies). Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registryo" J Autoimmun: 2009; 32 3-4 240 245
10. Espinosa G, Cervera R, Asherson RA. Catastrophic antiphospholipid syndrome and sepsis. A common link? J Rheumatol: 2007; 34 5 923 926 (Pubitemid 46774833)
11. Cervera R, Font J, Tincani A, Boffa MC. V meeting of the European forum on antiphospholipid antibodies. Autoimmun Rev: 2006; 5 499 507 (Pubitemid 44233400)
12. Cervera R, Tektonidou MG, Espinosa G., et al. Task Force on catastrophic antiphospholipid syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus: 2011; 20 2 165 173
13. Erkan D, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev: 2010; 10 2 74 79
14. Asherson RA, Espinosa G, Menahem S., et al. Relapsing catastrophic antiphospholipid syndrome: report of three cases. Semin Arthritis Rheum: 2008; 37 6 366 372 (Pubitemid 351734518)
15. Gmez-Puerta JA, Cervera R, Espinosa G., et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis: 2007; 66 6 740 746 (Pubitemid 46846692)
16. Cervera R, Espinosa G, Cordero A., et al. Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin Arthritis Rheum: 2007; 36 5 287 296 (Pubitemid 46517629)
17. Bucciarelli S, Espinosa G, Asherson RA., et al. Catastrophic Antiphospholipid Syndrome Registry Project Group. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis: 2006; 65 1 81 86 (Pubitemid 41815644)
18. Asherson RA, Espinosa G, Cervera R., et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis: 2005; 64 6 943 946 (Pubitemid 40733924)
19. Espinosa G, Bucciarelli S, Cervera R., et al. Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis: 2004; 63 6 730 736 (Pubitemid 38658405)
20. Uthman I, Shamseddine A, Taher A. The role of therapeutic plasma exchange in the catastrophic antiphospholipid syndrome. Transfus Apheresis Sci: 2005; 33 1 11 17 (Pubitemid 40982143)
21. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol: 2005; 29 3 173 184 (Pubitemid 43041668)
22. Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson RA.; Catastrophic Antiphospholipid Syndrome Project Group. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol: 2007; 34 2 346 352
23. Tenedios R, Erkan D, Lockshin MD. Rituximab in the primary antiphospholipid syndrome. Arthritis Rheum: 2005; 52 4078 [abstract]
24. Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome. Haematologica: 2004; 89 9 ECR34 [abstract]
25. Rubenstein E, Arkfeld DG, Metyas S, Shinada S, Ehresmann S, Liebman HA. Rituximab treatment for resistant antiphospholipid syndrome. J Rheumatol: 2006; 33 2 355 357 (Pubitemid 43209314)
26. Manner H, Jung B, Tonassi L., et al. Successful treatment of catastrophic antiphospholipid syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular weight heparin, rituximab and bendamustine. Am J Med Sci: 2008; 335 5 394 397
27. Nageswara Rao, Arteaga GM, Reed AM, Gloor JM, Rodriguez V. Rituximab for successful management of probable pediatric catastrophic antiphospholipid syndrome. Pediatr Blood Cancer. 2009; 52 4 536 538
28. Vora SK, Asherson RA, Erkan D. Catastrophic antiphospholipid syndrome. J Intensive Care Med: 2006; 21 3 144 159
29. Burcoglu-O'Ral A, Erkan D, Asherson RA. Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. J Rheumatol: 2002; 29 9 2006 2011 (Pubitemid 34988713)
30. Bucciarelli S, Espinosa G, Bov A, Cervera R, Asherson RA. Relapsing catastrophic antiphospholipid syndrome. Ann Rheum Dis: 2007; 66 Suppl II 304 [abstract]
31. Miyakis S, Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost: 2006; 4 2 295 306